Rhumbline Advisers Monte Rosa Therapeutics, Inc. Transaction History

Rhumbline Advisers

  • $104 Billion
  • Q1 2025

A detailed history of Rhumbline Advisers transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 62,239 shares of GLUE stock, worth $247,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,239
Previous 61,791 0.73%
Holding current value
$247,088
Previous $428,000 25.93%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025
BUY
$4.64 - $7.17 $2,078 - $3,212
448 Added 0.73%
62,239 $317,000
Q4 2024

Jan 30, 2025
BUY
$4.8 - $10.36 $44,750 - $96,586
9,323 Added 17.77%
61,791 $428,000
Q3 2024

Nov 12, 2024
BUY
$3.59 - $6.97 $16,309 - $31,664
4,543 Added 9.48%
52,468 $278,000
Q2 2024

Aug 01, 2024
BUY
$3.38 - $7.86 $4,637 - $10,783
1,372 Added 2.95%
47,925 $179,000
Q1 2024

May 09, 2024
BUY
$4.26 - $8.46 $5,082 - $10,092
1,193 Added 2.63%
46,553 $328,000
Q4 2023

Feb 08, 2024
SELL
$2.5 - $5.93 $607 - $1,440
-243 Reduced 0.53%
45,360 $256,000
Q3 2023

Nov 09, 2023
BUY
$4.78 - $7.22 $2,762 - $4,173
578 Added 1.28%
45,603 $218,000
Q2 2023

Aug 08, 2023
SELL
$4.53 - $8.4 $5,200 - $9,643
-1,148 Reduced 2.49%
45,025 $308,000
Q1 2023

May 11, 2023
BUY
$5.95 - $8.21 $13,827 - $19,080
2,324 Added 5.3%
46,173 $360,000
Q4 2022

Feb 14, 2023
BUY
$6.71 - $9.72 $5,951 - $8,621
887 Added 2.06%
43,849 $334,000
Q3 2022

Nov 10, 2022
BUY
$7.17 - $12.16 $17,294 - $29,329
2,412 Added 5.95%
42,962 $351,000
Q2 2022

Aug 11, 2022
BUY
$6.15 - $14.99 $100,601 - $245,206
16,358 Added 67.62%
40,550 $392,000
Q1 2022

May 12, 2022
BUY
$10.36 - $20.41 $250,629 - $493,758
24,192 New
24,192 $339,000
Q4 2021

Feb 10, 2022
SELL
$16.28 - $27.15 $150,313 - $250,675
-9,233 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$18.59 - $42.21 $171,641 - $389,724
9,233 New
9,233 $206,000

Others Institutions Holding GLUE

# of Institutions
108
Shares Held
53.4M
Call Options Held
69.1K
Put Options Held
22.4K
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $185M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email